Synventia Pharma Private Limited
About Synventia Pharma Private Limited
Data last updated:
Synventia Pharma Private Limited is a private limited company based in Nizampet, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2020PTC145357. Its GSTIN is 36ABECS7795N1ZC (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Srinivasa Rao Papineni and Venu Gopal Veldi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 108 – B Sri Laxmi Grand Block – B Srinivas Nagar Colony, Nizampet, Telangana, India – 500090.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.38 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹1.01 Lakh (net margin -0.7%) and EBITDA of -₹67,359 (EBITDA margin -0.5%).
Company details
Contact details
Synventia Pharma Private Limited's registered office is in Nizampet, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No 108 – B Sri Laxmi Grand Block – B Srinivas Nagar Colony, Nizampet, Telangana, India – 500090
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synventia Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synventia Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synventia Pharma Private Limited, buy the company report.
Financials of Synventia Pharma Private Limited
FY 2025 filings availableSynventia Pharma Private Limited reported revenue of ₹1.38 Cr (down 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year. EBITDA fell 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹67,359 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.01 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.5% | |||
| Net Profit Margin | -0.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Synventia Pharma Private Limited, buy the company report.
Board of directors of Synventia Pharma Private Limited
Synventia Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Rao Papineni Also directs: Aksaja Pharma Private Limited | Director | 05 May 2022 | 4 Years 5 Months | Current |
| Venu Gopal Veldi Also directs: Atom Fine Chemicals Private Limited, Chemxzen Labs Private Limited | Director | 28 Oct 2020 | 6 Years 0 Months | Current |
| Surendar Velagapuri Also directs: HTS Biopharma Private Limited | Director | 28 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Synventia Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Associated Smelters Private Limited | ₹1.39 Cr (FY 2024) | -4.0% | Mumbai, Maharashtra, India | |||
| Hyacinth Enterprises Private Limited | ₹1.38 Cr (FY 2018) | Mumbai, Maharashtra, India | ||||
| Vaishno Drugs & Intermediates Private Limited | ₹1.38 Cr (FY 2025) | 61.0% | Hyderabad, Telangana, India | |||
| Panorama Chempaint Private Limited | ₹1.38 Cr (FY 2024) | 4.0% | Allahabad, Uttar Pradesh, India | |||
| Aadhar Medichem Private Limited | ₹1.38 Cr (FY 2016) | -49.0% | Aurangabad, Maharashtra, India | |||
| Synventia Pharma Private Limitedthis company | ₹1.38 Cr (FY 2024) | -₹1.01 Lakh | -0.7% | -7.0% | Nizampet, Telangana, India | |
| Ma Earth Botanicals Private Limited | ₹1.38 Cr (FY 2025) | -3.0% | Gurgaon, Haryana, India | |||
| Minksun Agro Private Limited | ₹1.38 Cr (FY 2025) | 32.0% | Chandigarh, India | |||
| German Homoeo Care & Cure Private Limited | ₹1.38 Cr (FY 2025) | -8.0% | Ghaziabad, Uttar Pradesh, India | |||
| Fabetto Ecotech Private Limited | ₹1.38 Cr (FY 2025) | 13.0% | Roorkee, Uttarakhand, India | |||
| Lionskyob Products Private Limited | ₹1.38 Cr (FY 2025) | 21.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Synventia Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Synventia Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synventia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Synventia Pharma Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
Synventia Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABECS7795N1ZC | Telangana | Active | 27 Nov 2020 |
To see the full GST registrations and return filing status of Synventia Pharma Private Limited, buy the company report.
Recent activity
Synventia Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Srinivasa Rao Papineni was appointed as Director on 05 May 2022.
Frequently asked questions
Synventia Pharma is an active private limited company based in Nizampet, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 2020 (6+ years old) and is registered under CIN U24233TG2020PTC145357.
Synventia Pharma has 3 current directors:
- Srinivasa Rao Papineni - Director
- Venu Gopal Veldi - Director
- Surendar Velagapuri - Director
The latest financial statements of Synventia Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Synventia Pharma is 36ABECS7795N1ZC, registered in Telangana.
The CIN (Corporate Identification Number) of Synventia Pharma is U24233TG2020PTC145357. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synventia Pharma was incorporated on 28 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Synventia Pharma by revenue are Associated Smelters Private Limited, Hyacinth Enterprises Private Limited, Vaishno Drugs & Intermediates Private Limited, Panorama Chempaint Private Limited, Aadhar Medichem Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Srinivasa Rao Papineni was appointed as Director on 05 May 2022. Satyanarayana Boyina ceased to be Director on 19 Feb 2022. Surendar Velagapuri was appointed as Director on 28 Oct 2020. Synventia Pharma has 4 board changes on record in total.
The registered office of Synventia Pharma is at Flat No 108 – B Sri Laxmi Grand Block – B Srinivas Nagar Colony, Nizampet, Telangana, India – 500090.
Synventia Pharma operates in the pharma industry, in the drug formulation and development segment.
Synventia Pharma can be reached at its registered office: Flat No 108 – B Sri Laxmi Grand Block – B Srinivas Nagar Colony, Nizampet, Telangana, India – 500090.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
